Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $2.93 Analyst target: $1120.00 Upside: 38125.26%
Sunshine Biopharma, Inc., a pharmaceutical company, focuses on the development of anticancer drugs. The company is headquartered in Pointe-Claire, Canada.
See the full interactive analysis & chart →Informational only — not investment advice.